Status:
COMPLETED
Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan
Lead Sponsor:
Pfizer
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the long-term effectiveness and safety of CP-690,550 for the treatment of rheumatoid arthritis. Subjects are only eligible for this study after they have comp...
Eligibility Criteria
Inclusion
- Subjects who have completed their participation in a randomized "qualifying" study of CP-690,550 for the treatment of rheumatoid arthritis
Exclusion
- Serious medical conditions that would make treatment with CP-690,550 potentially unsafe
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
487 Patients enrolled
Trial Details
Trial ID
NCT00661661
Start Date
April 1 2008
End Date
December 1 2013
Last Update
May 12 2015
Active Locations (56)
Enter a location and click search to find clinical trials sorted by distance.
1
National hospital Organization Nagoya Medical Center
Nagoya, Aichi-ken, Japan, 460-0001
2
Nagoya University Hospital
Nagoya, Aichi-ken, Japan, 466-8560
3
National Hospital Organization Chiba-East Hospital
Chiba, Chiba, Japan, 260-8712
4
Chiba-ken Saiseikai Narashino Hospital
Narashino, Chiba, Japan, 275-8580